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Abstract 1 
Objective:   2 
With the increasing life expectancy for patients with cystic fibrosis (CF), and a known 3 
predisposition to certain cancers, cumulative radiation exposure from radiological imaging is of 4 
increasing significance. This study explores the estimated cumulative effective radiation dose 5 
over a 17 year period from radiological procedures, and changing trends of imaging modalities 6 
over this period.  7 
Methods:  Estimated cumulative effective dose (CED) from all thoracic and extra-thoracic 8 
imaging modalities and interventional radiology procedures for both adult and pediatric CF 9 
patients, exclusively attending a nationally designated CF center between 1992-2009 for 10 
>1year, was determined.  The study period was divided into 3 equal tertiles and estimated CED 11 
attributable to all radiological procedures was estimated for each tertile. 12 
Results:  230 patients met inclusion criteria (2,240 person-years of follow-up; 5596 radiological 13 
procedures). CED was >75mSv for 1 patient (0.43%), 36 patients (15.6%) had a CED between 20-14 
75mSv, 56 patients (24.3%) had a CED between 5-20mSv and in 138 patients (60%) the CED was 15 
estimated to be between 0-5mSv over the study period. The mean annual CED/patient 16 
increased consecutively from 0.39mSv/yr to 0.47mSv/yr to 1.67mSv/yr, over the tertiles 1-3 of 17 
the study period respectively (p<0.001). Thoracic imaging accounted for 46.9% of the total CED 18 
and abdomino-pelvic imaging accounted for 42.9% of the CED respectively.  There was an 19 
associated 5.9 fold increase in the use of all CT scanning per patient (p<0.001).  20 
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Conclusion:  This study highlights the increasing exposure to ionizing radiation to CF patients as 1 
a result of diagnostic imaging, primarily attributable to CT scanning. Increased awareness of 2 
CED and strategies to reduce this exposure are needed. 3 
MeSH Terms (3-5): Cystic Fibrosis [C08.381.187], Radiation Dosage [N06.850.810.250], 4 
Diagnostic Imaging [E01.370.350] 5 
Introduction:  6 
Experimental and epidemiological evidence has linked the cumulative exposure to ionizing 7 
radiation, even at low doses, with an age-dependent increased risk for the development of 8 
malignancy 
1-4
.  A number of recent studies have highlighted the issue of cumulative radiation 9 
exposure towards hospitalized patients
2,3
. However, few studies have addressed this issue in 10 
patients with chronic diseases and there are no studies to date quantifying the annual 11 
cumulative exposure to ionizing radiation incurred as a result of diagnostic and interventional 12 
radiology procedures for patients with cystic fibrosis (CF). With the progressive improvements 13 
in life expectancy for patients with CF, the cumulative exposure to ionizing radiation 14 
attributable to diagnostic imaging and interventional radiology procedures is of increasing 15 
significance
5-7
.   16 
A number of recent studies have highlighted that CF patients have an increased standardized 17 
incidence ratio (SIR; the ratio of the observed to the expected number of cancers in the cohort) 18 
of developing  a large number of  malignancies, with notable increases in the SIR for thoracic 19 
cancers , cancers of the digestive tract (SIR 5.6), kidney (SIR 14.0), thyroid (SIR 9.8) and 20 
lymphoma (SIR 7.3)
8
.  The issue of exposure to ionizing radiation in the diagnostic range in this 21 
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cohort raises additional concerns.   Linking the exposure of iatrogenic ionizing radiation to 1 
malignancy is controversial, however  data within the general population has approximately 2 
linked each 10 millisieverts (mSv) of radiation exposure to an incremental mean increase risk in 3 
cancer of 1 radiation induced malignancy per 1000 patients, although this risk is significantly 4 
affected by both age of exposure and gender
9-10
.  Secondly, previous studies have proposed 5 
that additional caution is required in patient sub-groups (e.g. Crohn’s disease patients) who 6 
because of their chronic relapsing illnesses require repeated diagnostic imaging throughout 7 
their lifetime and who already have an increased lifetime risk of developing cancer, may suffer 8 
as a result of possible synergy between these two factors resulting in an ever higher incidence 9 
of developing cancer 
11
.  10 
The benefits of radiological imaging are well proven and have been comprehensively 11 
characterized for CF patients
12-14
.  In CF patients, thoracic CT can detect lung changes from early 12 
infancy and before they become apparent by pulmonary function testing 
15-16
.   An increasing 13 
number of clinical trials are using thoracic CT scores as surrogate end points in their studies 
17-
14 
18
.  Additionally, some centers use high resolution CT in the routine monitoring of disease 15 
progression for pediatric patients with CF
19
. 16 
This is the first study to examine the cumulative effective radiation dose (CED) incurred by a 17 
cohort of adult and pediatric patients with CF, and the changing trends in use of radiological 18 
imaging modalities in this cohort, over 17 years. It is also the first study to characterize relative 19 
anatomical radiation distribution including the percentage of cumulative exposure arising from 20 
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thoracic and abdomino-pelvic imaging and the relationship between clinical phenotype and 1 
CED. 2 
Methods:  3 
Study Population: 4 
All pediatric and adult patients with CF who exclusively attended a nationally designated Adult 5 
or Pediatric CF center , for all medical therapy for > 1year from the 1
st
 July 1992 to the time of 6 
lung transplantation, hospital treatment transfer or death until the study end date of 1
st
 May, 7 
2009 were included in this study.  Ethical approval for the study was granted by the institution’s 8 
research ethics committee.  Approval number (reference number) for this study: ECM 9 
4(z)03/03/09. All demographic, clinical data and hospital attendances were obtained by chart 10 
review.  Lung function was measured in accordance with the standards set out by the European 11 
Respiratory Society and recorded as maximum annual FEV1% predicted using the European 12 
Community for Coal and Steel (ECCS) reference values
20
. 13 
Data Source: 14 
Details of all imaging studies and interventional radiology procedures performed on adult 15 
(>18yrs) and pediatric (<18yrs) patients in the study 
 
cohort over the 17 year study period 1
st
 16 
July 1992 to 1
st
 May 2009 were obtained from the computerized radiology information system 17 
of the radiology department. All studies were requested for clinical purposes only, by 18 
experienced hospital clinicians, predominantly by attending pediatricians and attending 19 
pulmonologists with a special interest in cystic fibrosis.  The CED was measured in millisieverts 20 
(mSv), a measure designed to represent the overall detrimental effect of a non-uniform ionizing 21 
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radiation exposure and useful for population-level comparisons across different
 
types of 1 
radiation exposure 
21
.  As per previous studies 
11 22
, estimations were based on a recent article 2 
by Mettler at al, which provided a compilation of the mean effective doses for radiological and 3 
nuclear medicine examinations from the recent published literature, across the USA, Canada, 4 
Japan, Australia and Western Europe,  over a similar time period as this study
23
.  In 5 
circumstances where this source was insufficient, estimates were calculated from other 6 
published sources or extrapolated from doses reported
 
for similar procedures relevant to our 7 
studied population over a similar time period and using similar dose calculation methodology 
24
.  8 
CED was determined for general radiography (Gen), computed tomography (CT), general 9 
interventional procedures (GIV), nuclear medicine (NM), fluoroscopy (Fl) including all barium 10 
examinations (Ba), and data were then subcategorized into the anatomical area imaged as 11 
thoracic, abdomino-pelvic and other.  All computed tomography (CT) scans during the study 12 
period (1992-2009) were performed using either an incremental protocol on either a single slice 13 
CT (Siemens Medical Solutions, Erlangen Germany) or a four slice detector CT (Toshiba Aquilon, 14 
Toshiba Medical Systems, Zoetermeer, The Netherlands). 15 
Pediatric effective doses for chest radiographs, abdominal films and barium studies were 16 
calculated using the presets for pediatric patients aged 1, 5, 10 and 15 years in the software 17 
package PCXMC (version 1.5)
25
  in conjunction with local hospital exposure parameters and 18 
protocols.  Typified normalized effective doses for pediatric CT scanning were calculated based 19 
on validated anatomically-specific Monte Carlo phantom simulations for 1, 5, 10 and 15 year 20 
olds
23
 (table 1) .  21 
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Statistical Analysis:  1 
The study period was divided into three tertiles of equal duration from 1
st
 July 1992- 28
th
 2 
February 1998 (Tertile 1), 1
st
 March 1998-30
th
 November 2003 (Tertile 2), and 1
st
 December 3 
2003-1
st
 May 2009 (Tertile 3).  Data compilation and statistical analyses were performed using 4 
Microsoft Access 2007 (Microsoft Corporation, Washington, USA) and SPSS version 15 (SPSS Inc, 5 
Chicago IL, USA).  Algorithms calculating the age of each patient at time of scanning and 6 
adjusting to the closest categorical age of 1, 5, 10, 15 years old or adult as appropriate were 7 
established and the person years of follow up in each tertile determined.  Comparison between 8 
groups was performed using Mann Whitney U tests or Pearson’s Chi-squared for categorical 9 
variables. Spearman analysis was used for comparisons of non-parametric data where 10 
appropriate.  Comparison across 3 or more groups was performed using ANOVA or Kruskal 11 
Wallis tests in accordance with their distribution.  A type I error rate ≤ 0.05 was considered 12 
significant.  13 
Results:  14 
Study population: 230 patients met inclusion criteria and were included in the final analysis.  15 
The mean age of patients at the end of tertile 3 was 21.5 years (SD +/-11.6); mean FEV1 % 16 
predicted was 65.8% (SD +/- 27.3%).  7 patients received lung transplantations during the study 17 
period and 42 patients died during the study period, 1 from hepatocellular carcinoma. 18 
Imaging Modality: 19 
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There were 5596 radiological procedures: General radiographs n= 4730, Ultrasonography n= 1 
406, CT n= 241, interventional procedures n=127, fluoroscopy n=74 and nuclear medicine n=18, 2 
over the 2,240 person years of follow up.  3 
Cumulative Effective Dose: 4 
Over the total study period 1 patient (0.43%) had a CED >75mSv, 6 patients (2.6%) had a CED 5 
50-75mSV, 30 patients (13%) had a CED 20-50mSv, 26 patients (11.3%) had a CED 10-20mSv, 29 6 
patients (12.6%) had a CED 5-10mSV and 138 patients (60%) had a CED between 0-5mSv. In 7 
total 63/230 (27.4%) of patients had a CED >10mSv over the study period. Plain radiographs 8 
account for 74% of the total number of studies, resulting in 6% of total cumulative radiation 9 
exposure for the most recent tertile (tertile 3, see figure 1).  Conversely, CT accounted for 8% of 10 
total number of studies whilst resulting in 74.8% of total radiation exposure in tertile 3 (Figure 11 
1).  A breakdown analysis of the 10% of patients with the highest CED showed 61.9% related to 12 
CT, 10.4% from fluoroscopy, 12.7% from general radiography and 15.0% from interventional 13 
procedures. 14 
 15 
Changing trends over time: 16 
The mean number of radiological procedures for tertile 1-3 was 2.89 procedures per person per 17 
year for tertile 1, 2.7 procedures per person per year for tertile 2 and 2.71 procedures per 18 
person per year for tertile 3.  The equivalent annual mean effective dose (aMED) was 0.39 mSv 19 
per person per year for tertile 1, 0.47mSv  per person per year for tertile 2 and 1.67mSv per 20 
person per year for tertile 3 (p<0.001) (table 2).  The increased aMED predominantly related to 21 
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a 5.9 fold increase in the number of CT studies over this time (p<0.001). Similar trends were 1 
seen in the pediatrics’ subgroup analysis (table2).   2 
Correlation between clinical phenotype and CED: CED correlated with age (r=0.307; p<0.001) 3 
and in subgroup analysis of adult patients at the end of tertile 3, CED correlated inversely with 4 
FEV1% predicted (r=0.182; p<0.04).  There was no correlation between mean annual effective 5 
dose and gender (p=0.125) or cystic fibrosis class mutation (p=0.122). 6 
Anatomical Area Imaged: 7 
Cumulative radiation exposure, for the whole population, from thoracic imaging, as a 8 
percentage of total CED was 46.9% over the 3 tertiles with relative exposure of 36%; 34.4% and 9 
51.7% for tertiles 1-3 respectively, correlating with the increased use of CT thorax.  Of the total 10 
radiation exposure to the thorax, 76.4% (748mSv) was from CT thorax (n=130 scans of thoracic 11 
region), 9.5% (71.3mSv) from plain radiography, 0.8% (7.93mSv) from fluoroscopy, and 15.5% 12 
(152mSv) from interventional procedures (figure 2) 13 
Cumulative radiation exposure, for the whole population, from abdominal imaging as a 14 
percentage of total CED was 42.7% over the 3 tertiles with cumulative exposure per tertile of 15 
50%; 45.3% and 41% for tertiles 1-3 respectively reflecting both an increased use of abdomino-16 
pelvic CT imaging with a decreasing use in fluoroscopy.  Overall the CED to the abdomino-pelvic 17 
area increased significantly across the 3 tertiles, however there was a relative decrease in the 18 
percentage contribution from abdomino-pelvic imaging due to the more significant increase in 19 
thoracic imaging over the same time period.  Of the total radiation exposure to the abdomino-20 
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pelvic region; 53.5% was from abdomino-pelvic CT imaging, 11.9% from plain radiography, 1 
25.6% from fluoroscopy, and 9.0% from interventional procedures.   2 
 3 
Discussion:  4 
This is the first study to calculate annual CED from all diagnostic imaging and interventional 5 
radiology procedures in patients with cystic fibrosis.  27.3% of our patients had an estimated 6 
CED exposure of >10mSv over the study period.  Although controversial, an exposure of 10mSv 7 
of radiation dose has been predicted to result on average in 1 radiation induced malignancy per 8 
1000 patients
10
.  Recent studies have highlighted the increased risk for certain malignancies in 9 
patients with CF
8
.     Several epidemiological
 
studies have shown direct evidence of increased 10 
cancer-related
 
mortality following long-term exposure to low levels of ionizing
 
radiation, 11 
including diagnostic radiation 
10 26
, and that this cancer risk follows a “linear no threshold” risk, 12 
indicating all radiation exposure may pose a risk of developing cancer
27
. Studies have suggested 13 
that the majority of physicians are not aware of the effective radiation dose associated with 14 
radiological procedures, nor do they discuss the risks and benefits of CT and other imaging 15 
examinations with their patients 
28
. One study found 75% of radiologists and physicians 16 
significantly underestimated the radiation dose from a CT scan 
28
.    Our paper address’s these 17 
issues and generates a summary of effective doses for common adult and pediatric imaging 18 
modalities, which clinicians can apply to their practice. 19 
The present study demonstrates a significant increase in the annual mean effective dose to our 20 
patients over the past 17 years, with a mean annual exposure of 1.67mSv per patient in the 21 
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most recent tertile. This dose may appear relatively modest, given for example a background 1 
environmental radiation exposure annually of ~3.9mSv/yr amongst the Irish population
29
, 2 
however this represents a significant exposure for such a young cohort of patients, made all the 3 
more pertinent given the progressive increased life expectancy for these patients with 4 
improved management of cystic fibrosis
4
.  Over the 3 tertiles the frequency of medical imaging 5 
remained relatively constant; however there was a significant shift in the use of imaging 6 
modalities. The single largest contributing factor to the increased radiation exposure was the 7 
5.9 fold increase in all CT imaging (thoracic, abdomino-pelvic and other) from the 1
st
 tertile to 8 
the 3
rd
 tertile.  This is consistent with international data on the rapidly increasing
 
availability 9 
and utilization of CT imaging in clinical medicine 
30
.   10 
The changing trends in radiation exposure held similar results for both adult and pediatric 11 
populations.  The pediatric effective doses we established, are frequently much larger than 12 
adult doses (table 1), this is due to the  thinner torso in children providing less shielding of 13 
organs from the radiation exposure
1
.  In CT, based on the exposure factors used and in the 14 
absence of tube current modulation, there is a decrease in effective dose with increasing age.   15 
This relates to the increased dose administered per unit of body mass for children as 16 
highlighted recently in the “Image Wisely” campaign of the joint North American task force on 17 
adult radiation protection
31
.  Plain film radiography, however allows for greater dose reduction 18 
in children, as the exposure parameters required are significantly lower than those used in CT.  19 
Increased radiosensitivity in children still exists but the radiation dose decreases with 20 
decreasing age, resulting overall in a decreasing effective dose
32
.   The increasing use of CT 21 
imaging as a routine procedure in some centers and the recent studies which suggest that HRCT 22 
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findings frequently pre-date changes in lung function and chest radiograph for pediatric 1 
patients, highlights the need to develop further strategies to minimize the risks of radiation 2 
exposure to these patients
33
.   Children, particularly females, are inherently more sensitive to 3 
radiation exposure.  This radiosensitivity relates to a large proportion of dividing cells and a 4 
longer time for a potential cancer to develop
1
.   De Gonzalez et al estimated the lifetime risk of 5 
radiation induced cancer for CF patients from a modern HRCT thorax  protocol at 2 years of age 6 
to be 24 per 100,000 for females versus 6 per 100,000 males, reducing to 1 per 100,000 for a 50 7 
year old female and 0.3 per 100,000 for a 50 year old male
34
.    The studies to date predicting 8 
radiation induced cancer risk from annual thoracic CT for CF patients
34
 have assumed the 9 
cancer rates to be the same as the general population, however recent data supports an 10 
increased standardized incidence risk ratios for all cancers in CF patients, suggesting these 11 
patients may have an intrinsic increased risk of malignancy.   For anatomical reasons, the 12 
thyroid radiation exposure is higher in pediatric patients undergoing chest radiographs and 13 
thoracic CT imaging and  the routine use of thyroid and breast shields should be seriously 14 
considered in this cohort of patients 
35
. 15 
Despite the fact that greater than 90% of CF patients die from respiratory failure, this study 16 
highlights that over half of all radiation exposure is related to extra thoracic imaging modalities, 17 
contrary to what one might have expected. CF is a multi-system disorder and patients with 18 
cystic fibrosis are particular prone to both primary and secondary gastrointestinal disturbances 19 
including constipation, distal intestinal obstruction syndrome, acute and chronic pancreatitis 20 
and nutritional deficiency. These conditions frequently require diagnostic imaging, which is 21 
often of a significantly higher radiation dose than thoracic imaging
36
.  In our cohort of patients, 22 
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42.7% of radiological imaging was directed at the abdomino-pelvic region. There are consistent 1 
reports of an increased standardized incidence ratio for digestive tract and other abdominal 2 
malignancies in CF patients compared to the general population 
8 37
.  This malignancy risk is 3 
likely to be multifactorial, potentially as a result of the inflammation associated with chronic 4 
pancreatitis 
38
, low serum vitamin D levels  and an increasing frequency of lung transplantation 5 
with associated immunosuppression
39
.  The high abdomino-pelvic radiation exposure is likely to 6 
pose an additional risk factor for these malignancies.   7 
There are a number of available strategies for reducing radiation exposure in patients with CF
40
.  8 
Patients with CF frequently have a smaller body habitus and reduced body mass indices, so 9 
specific low-dose CF protocols optimizing specific parameters such as the millamperes (mA) to 10 
patient weight need to be considered
41
. Reducing the mAs from 180 to 45 for a conventional 11 
thoracic HRCT scan can result in a 4 fold reduction in radiation exposure without any significant 12 
difference in image quality 
42
.   Additionally, over 97% of CT Thorax scans have significant supra-13 
apical and infra-pulmonary unnecessary imaging, resulting in increased exposures to the 14 
thyroid and abdominal regions 
43
.  For incremental CT thorax imaging in CF patients, the validity 15 
of reducing the number of images per CT examination has generated conflicting results, one 16 
study has shown an equivalent score using CT cuts from 6 pre-selected sections in a cohort of 17 
children with CF 
44
, whilst others report a reduced sensitivity to detect changes when the image 18 
interval is >10mm in children with CF 
45
.       With proper attention to detail of scanning 19 
parameters radiation dose can be reduced substantially compared to routine chest CT. 20 
Strategies currently available for optimization of CT radiation dose include the use of automatic 21 
tube current modulation, iterative reconstruction techniques and noise reduction filters which 22 
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can lead to significant reduction in radiation exposure without significant impact on image 1 
quality
27
.   As a result of the preliminary results  of this study, we recently implemented a new 2 
thoracic low dose thin slice CT protocol for pediatric patients with CF which achieved significant 3 
reductions in mean effective doses
14
.  Close attention needs to be given to the information 4 
gained from each imaging request to ensure that the examination is indicated and could not be 5 
replaced by an imaging study which does not expose the patient to ionizing radiation (e.g. 6 
ultrasound or MRI).  Also it is very important to limit exposure to extra-thoracic organs 7 
including the development of low dose abdomino-pelvic CT protocols.   8 
The advantage of detecting early changes on CT imaging awaits additional confirmation, some 9 
authorities feel strongly that the structural information gained by the use of CT scanning helps 10 
to tailor treatments, reducing under and over treatment for patients, but to date there are no 11 
studies proving such a benefit 
13 19
. The current guidelines suggest there is insufficient evidence 12 
to recommend use of chest CT scans for routine surveillance but suggest chest CT scanning may 13 
be helpful in infants with symptoms or signs of lung disease who fail to respond to basic 14 
interventions
46
.   Future studies are also needed to delineate the role of novel strategies in 15 
thoracic imaging, including the use of hyperpolarized helium magnetic resonance imaging
47
  16 
and positron emission tomography
40
. 17 
This study has a number of limitations, notably it represents the radiation exposure in a 18 
single tertiary referral cystic fibrosis center.  However, the use of a nationally designated CF 19 
center acting as both the primary and secondary care facility, regardless of health insurance 20 
status, ensured the accuracy of capturing of all imaging studies for this cohort of patients.  We 21 
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acknowledge that retrospective radiation dose exposures appropriate for the period of study 1 
involved were used.  With technological advances it has been suggested that a reduction in 2 
radiation exposure of over 75% can be safely achieved using more modern low-dose CT thorax 3 
protocols 
48
, however this may be offset with the increasing use of spiral CT scanning and 4 
potentially by the recent suggestions to monitor disease progression using  combined PET/CT 5 
imaging
49-50
. The modern use of helical CT scanning in CF patients
51
 has increased the diagnostic 6 
sensitivity in detecting peripheral thoracic changes
33
 but incurs significantly higher radiation 7 
exposures compared to standard incremental scans of up to 3 mSv per CT thorax.   Inevitably 8 
there will be variation in clinical practice between centers’, one previous French study 9 
identified a mean cumulative effective dose from CT scans in CF patients of 19.5 mSv 
52
, with a 10 
mean patient exposure to 3.4 CT scans.  The annual radiation exposure in our cohort of patients 11 
with CF is relatively low, with mean annual exposures of 1.667mSv in the most recent tertile 3, 12 
this compares to an annual exposure dose of 8.1mSv in a cohort of patient with Crohn’s disease 13 
at the same institute.  It is important to note that only 1 patient (0.43%) had an exposure of 14 
>75mSv over the 17 yr period, compared to 15.5% of Crohn’s patients
15
 and 13% of 15 
hemodialysis patients having an exposure of >75mSv over the same time period at our 16 
institute
16
. However, the critical difference is the young age patients with CF are exposed to 17 
radiation and the chronic progressive nature of CF from early childhood. Our center follows the 18 
3 fundamental principles of  radiation protection: justification, dose optimization through the 19 
“as low as reasonably achievable” (ALARA) principle and dose limitation, as set out in the 20 
International Commission of Radiological Protection 
53
.. As a result of this, we have not yet 21 
adopted the use of routine CT scanning into clinical practice given the absence of any proven 22 
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16 
benefit in clinical outcome for such a measure
52
. This study is therefore likely to represent a 1 
conservative estimate for the annual cumulative effective dose for radiological imaging in CF 2 
patients and for the changing trends in CT imaging over the past 17 years. Urgent consideration 3 
should be given to the development of low-dose imaging protocols and to regular monitoring 4 
and recording of CED for  patients, particularly in identifiable groups where exposure levels may 5 
become high, as in our cohort and in many chronic diseases.  Strategies to prospectively 6 
monitor cumulative dose may include recommendations such as: the creation of dose 7 
registries; the mandatory recording of dose within the examination images or report, recording 8 
of dose within the patient’s medical record and mandatory accreditation of imaging facilities.  9 
As a result of this study we are currently implementing a policy of recording the effective dose 10 
through the picture archive communication system (PACS) at our institute, to allow for ongoing 11 
monitoring and auditing of radiation exposure with each imaging examination
54
. 12 
Conclusion: 13 
Patients with CF are exposed to high radiation doses from a young age, exacerbated by the 14 
increasing use in CT imaging.  Strategies need to be developed and implemented with regard to 15 
radiation exposure reduction for both thoracic and extra-thoracic imaging in this cohort of 16 
patients.  17 
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 36 
Legend for Table 1: The effective doses of frequent medical imaging procedures used for CF 37 
patients. 38 
 39 
Legend for Table 2: Total radiation dose per patient year (PPY) across the 3 tertiles for all 40 
study subjects and secondly for pediatric patients only.    41 
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Legend for Figure 1: Relative contribution of each radiological imaging modality to cumulative 1 
radiation exposure for tertile 3. 2 
Legend for Figure 2: Regional percentage breakdown of total radiation dose exposure to 3 
thorax, abdomino-pelvic and other body parts over tertiles 1-3 for the studied population 4 
(adult and pediatric inclusive).  5 
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Procedure 1yr 
(mSv) 
5yr 
(mSv) 
10yr 
(mSv) 
15yr 
(mSv) 
≥18yr 
(mSv) 
CXR PA 0.003 0.005 0.01 0.014 0.02 
Radiograph of abdomen 0.02 0.04 0.1 0.14 0.23 
Conventional CT Thorax 13.3 11.2 9.8 7.7 7.0 
HRCT Thorax 2.85 2.4 2.1 1.65 1.5 
CT abdomen 16 12.8 12 8.8 8 
CT Pulmonary Angiogram 28.5 24 21 18 15 
Barium Meal 1.28 0.82 0.93 1.63 2.32 
Barium Swallow 1.16 0.78 1.09 0.75 0.77 
Radiograph Lumbar Spine     1.5 
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Population 
 
All subjects
 
 
 
 
Pediatrics  only
 
 
 
Tertile 1st 2nd 3rd p-value 
 
1st 2nd 3rd p-value 
 
Number of subjects 132 157 199 
 
105
 
115
 
115
 
 
 
Cumulative Follow Up 
(years) 599.8
 
702.6
 
938.0
 
 
 
435.83
 
452.17
 
470.67
 
 
 
All investigations 
 
Number PPY 2.89 
 
2.70 
 
2.71 
 
0.86
 
2.82 
 
    2.49
 
2.04
 
0.11
 
Total dose PPY, (mSv)  0.39 
 
0.47 
 
1.667 
 
<0.001
 
0.403 
 
0.303 
 
0.788 
 
0.01
 
Chest Radiographs only 
No. PPY  2.07 
 
1.93 
 
1.66 
 
0.31
 
1.98 
 
1.76 
 
1.35
 
0.03
 
Total dose PPY, (mSv)   0.03 
 
0.03 
 
0.03 
 
0.92
 
0.02 
 
0.02 
 
0.02 
 
0.22
 
Abdominal Radiographs Only 
No. PPY 0.23 
 
0.24 
 
0.19 
 
0.81
 
0.23 
 
0.27 
 
0.07 
 
0.11
 
Total dose PPY, (mSv)  0.03  0.03  0.04  0.76 0.03  0.03  0.008  0.07 
Total  CT 
No. PPY   0.035 
 
0.046 
 
0.210 
 
<0.001
 
0.042 
 
0.033 
 
0.108 
 
0.006
 
Total dose PPY (mSv)  0.136      0.179 1.27  <0.001
 
0.192 
 
0.084 
 
0.581 
 
0.002 
 
Thoracic CTs only 
No. PPY  0.015 
 
0.018 
 
0.125 
 
<0.001
 
0.024 
 
0.018 
 
0.063 
 
0.01
 
Total dose PPY, (mSv)  0.087 
 
0.061 
 
0.778 
 
<0.001
 
0.146 
 
0.045 
 
0.327 
 
0.02
 
Abdomino-Pelvic CT Only 
No. of PPY 0.001 
 
0.010 
 
0.058 
 
<0.001
 
0.002 
 
0.002 
 
0.028 
 
0.001 
 
Total dose  PPY, (mSv) 0.008 
 
0.082 
 
0.444 
 
<0.001
 
0.010 
 
0.012 
 
0.218 
 
0.001 
 
Other CTs 
No. PPY  0.019 
 
0.018 
 
0.027 
 
0.65
 
0.017 
 
0.014 
 
0.018 
 
0.94
 
Total dose PPY (mSv) 0.041 
 
0.036 
 
0.054 
 
0.68
 
0.036 
 
0.027 
 
0.036 
 
0.92
 
Total interventional studies 
No. of PPY 0.034 
 
0.039 
 
0.101 
 
0.01
 
0.018 
 
0.016 
 
0.033 
 
0.55
 
Total dose PPY (mSv) 0.038  
 
0.069  0.172 0.06
 
0.019 
 
0.008 
 
0.086 
 
0.06
 
Total Barium Studies 
No. PPY 0.048 
 
0.039 
 
0.014 
 
0.01
 
0.048 
 
0.048 
 
0.012 
 
0.03
 
Total dose PPY (mSv) 0.104 
 
0.093 
 
0.055 
 
0.36
 
0.096 
 
0.107 
 
0.026 
 
0.05
 
Total Nuclear Medicine Studies 
No. PPY 0.001  0.009  0.011  0.29 0.002  0.008 0.006 0.37 
Total dose PPY (mSv) 0.009 
 
0.051 
 
0.063 
 
0.37
 
0.011 
 
0.038 
 
0.034 
 
0.49
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